SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001140361-24-028123
Filing Date
2024-05-30
Accepted
2024-05-30 16:25:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFR14A ef20030204_defr14a.htm DEFR14A 31975
2 image01.jpg GRAPHIC 4299
  Complete submission text file 0001140361-24-028123.txt   39280
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-34079 | Film No.: 241005661
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)